Novo Integrated Sciences (NVOS) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Novo Integrated Sciences Revenue Highlights


Latest Revenue (Y)

$12.57M

Latest Revenue (Q)

$3.15M

Main Segment (Y)

Corporate Segment

Novo Integrated Sciences Revenue by Period


Novo Integrated Sciences Revenue by Year

DateRevenueChange
2023-08-31$12.57M7.11%
2022-08-31$11.74M26.14%
2021-08-31$9.31M18.38%
2020-08-31$7.86M-16.57%
2019-08-31$9.42M5.93%
2018-08-31$8.89M11.70%
2017-08-31$7.96M10.93%
2016-08-31$7.18M100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31-100.00%
2005-12-31-100.00%
2004-12-31--

Novo Integrated Sciences generated $12.57M in revenue during NA 2023, up 7.11% compared to the previous quarter, and up 141.35% compared to the same period a year ago.

Novo Integrated Sciences Revenue by Quarter

DateRevenueChange
2024-05-31$3.15M-0.59%
2024-02-29$3.17M-18.52%
2023-11-30$3.89M17.80%
2023-08-31$3.30M0.31%
2023-05-31$3.29M28.81%
2023-02-28$2.56M-25.23%
2022-11-30$3.42M-141.98%
2022-08-31$-8.15M-158.80%
2022-05-31$13.85M382.77%
2022-02-28$2.87M-9.26%
2021-11-30$3.16M17.42%
2021-08-31$2.69M13.10%
2021-05-31$2.38M14.70%
2021-02-28$2.08M-3.69%
2020-11-30$2.16M16.84%
2020-08-31$1.84M77.69%
2020-05-31$1.04M-57.25%
2020-02-29$2.43M-4.70%
2019-11-30$2.55M5.30%
2019-08-31$2.42M-2.79%
2019-05-31$2.49M13.14%
2019-02-28$2.20M-4.81%
2018-11-30$2.31M6.45%
2018-08-31$2.17M-6.52%
2018-05-31$2.32M8.26%
2018-02-28$2.15M-4.78%
2017-11-30$2.25M1.51%
2017-08-31$2.22M6.24%
2017-05-31$2.09M100.00%
2017-02-28--100.00%
2016-12-31$1.82M-0.94%
2016-09-30$1.84M100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31-100.00%
2007-09-30-100.00%
2007-06-30--

Novo Integrated Sciences generated $3.15M in revenue during Q3 2024, up -0.59% compared to the previous quarter, and up 123.29% compared to the same period a year ago.

Novo Integrated Sciences Revenue Breakdown


Novo Integrated Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceAug 23Aug 22Aug 21
Corporate Segment$9.70K$3.18K-
Healthcare Services-$8.40M$8.86M
Product Sales-$3.34M-
Product Manufacturing and Development--$447.56K

Novo Integrated Sciences's latest annual revenue breakdown by segment (product or service), as of Aug 23: Corporate Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceMay 24Nov 23Aug 23May 23Aug 22May 22Feb 22Nov 21
Product Manufacturing And Development$968.52K-------
Corporate Segment-$78.25K------
Product Manufacturing and Development---$1.27M$995.65K$982.30K--
Healthcare Services---$2.02M$2.14M---
Product Sales----$-10.29M$11.65M--
HealthCare Services-----$2.20M$1.87M$2.18M

Novo Integrated Sciences's latest quarterly revenue breakdown by segment (product or service), as of May 24: Product Manufacturing And Development (100.00%).

Novo Integrated Sciences Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
THCTenet Healthcare$20.55B$5.12B
UHSUniversal Health Services$14.28B$3.91B
CYHCommunity Health Systems$12.49B$3.09B
DVADaVita$12.14B$3.26B
AGLagilon health$4.32B$1.48B
AMNAMN Healthcare Services$3.79B$740.68M
BKDBrookdale Senior Living$3.02B$777.54M
ACHCAcadia Healthcare Company$2.93B$815.63M
CANOCano Health$2.74B$788.07M
AVAHAveanna Healthcare$1.90B$490.65M
PIIIP3 Health Partners$1.27B$388.49M
LFSTLifeStance Health Group$1.06B$300.44M
PNTGPennant Group$544.89M$156.91M
TOIOncology Institute$324.24M$94.67M
NVOSNovo Integrated Sciences$12.57M$3.15M
BACKIMAC$5.20M-

NVOS Revenue FAQ


Novo Integrated Sciences's yearly revenue for 2023 was $12.57M, representing an increase of 7.11% compared to 2022. The company's yearly revenue for 2022 was $11.74M, representing an increase of 26.14% compared to 2021. NVOS's yearly revenue for 2021 was $9.31M, representing an increase of 18.38% compared to 2020.

Novo Integrated Sciences's quarterly revenue for Q3 2024 was $3.15M, a -0.59% decrease from the previous quarter (Q2 2024), and a -4.28% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $3.17M, a -18.52% decrease from the previous quarter (Q1 2024), and a 24.02% increase year-over-year (Q2 2023). NVOS's quarterly revenue for Q1 2024 was $3.89M, a 17.80% increase from the previous quarter (Q4 2023), and a 13.80% increase year-over-year (Q1 2023).

Novo Integrated Sciences's revenue growth rate for the last 3 years (2021-2023) was 35.11%, and for the last 5 years (2019-2023) was 33.44%.

Novo Integrated Sciences's revenue streams in g 23 are Corporate Segment

For the fiscal year ending Aug 23, the largest source of revenue of Novo Integrated Sciences was Corporate Segment. This segment made a revenue of $9.7K, representing 100.00% of the company's total revenue.